POSITIVE ALSO:
Thanks Change! If all this is true than the question is whether Cyrcadia US is going to issue the serie A shares (6,5M) If not than the dilution of Cyrcadia is less.
Below stated is just DD in combination with my common sense!!
In my earlier post I calculated that after exercising the option LLBO AND after raising 6,5M, would have 12,67M of 35,17M=36%
If those 6,5 is not necessary to raise the total OS Cyrcadia US will only be 28,67M
LLBO would have 12,67 of 28,67=
46% (!!!) of Cyrcadia US
SO MAYBE CYRCADIA US GETS LESS OF THE PIE BECAUSE OF CYRCADIA AS. BUT LLBO GETS RELATIVELY 20% EXTRA OF CYRCADIA US!!
This is why raising extra money WOULD NOT be necessary:
The funding of 6,5M was meant to be
1. For exercising the option for the patents of LLBO
2. For the enrollment of the ITBra in Asia.
Read the text under written.
Especially (!!!) those passages.
Press release:
CI has entered into a License and Cooperation Agreement Cyrcadia Asia, Ltd. (CA), a newly formed company in Hong Kong which will serve as the base for the Asia market launch of CI’s proprietary iTBraTM technology expected to commence in late 2017 or early 2018 under the global CI brand of Cyrcadia Health.
The License and Cooperation Agreement also provides for certain other financial terms between the two parties intended (!!!)to enable the launch of the technology and products in Asia (!!!)
“The License and Collaboration Agreement between CI and CA brings advantages for both parties,” said Royea. “The opportunity for early market entry and funding from the Asian operations (!!!)brings additional funding into CI to exercise its option, under an Intellectual Property Asset Option Agreement with the technology’s developer to acquire directly certain patents which previously had been licensed to CI (!!!). Those patents are in the process of transferring to CI to be fully owned by CI, and they are licensed to CA under the License and Collaboration Agreement.
still going for that Italian castle...????????
